Skip to main content

Table 2 Questions posed to participants for the second round table discussion

From: Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group

Quantifying effectiveness: what outcome measures are needed?

Quantifying effectiveness: how can observer biasbe minimized?

How can adherence be assessed in study setting/real life?

What should be priorities in qualitative surveys around adherence?

What public health interventions are needed to increase effectiveness of PQ?